Search for: "ELI LILLY "
Results 41 - 60
of 2,172
Sorted by Relevance
|
Sort by Date
1 Nov 2006, 5:35 am
A recent article in the NY Times highlighted the problems surrounding Eli Lilly's sepsis drug Xigris. [read post]
17 Dec 2008, 6:17 pm
Eli Lilly, a US drugmaker, lobbied for 3.3 million dollar in the third quarter of 2008 on issues, which include counterfeiting problems and regulatory reform in China, according to the Associated Press. [read post]
8 Sep 2014, 5:00 am
With the current West African outbreak of Ebola making major news headlines in recent weeks, we were greatly intrigued to see one Eli Lilly invention that could be used to treat Ebola and other major viral infections, like HIV. [read post]
13 Oct 2013, 12:21 pm
Not all of Eli Lilly and Company’s developments are strictly related to human health. [read post]
24 Jan 2011, 12:31 pm
On January 20, 2011, Eli Lilly and Company of Indianapolis, Indiana (“Lilly”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337. [read post]
15 Feb 2013, 9:00 pm
Read more: Latham Guides Eli Lilly to $29.4 Million FCPA Settlement [read post]
10 Oct 2017, 7:30 am
Although sales of Alimta have dropped in recent months, the cancer treatment remains an important part of Eli Lilly’s portfolio. [read post]
6 Sep 2022, 3:28 pm
To get to the jury, the whistleblower had to beat back Eli Lilly’s challenge under the U.S. [read post]
24 Jul 2014, 9:06 am
The Wall Street Journal notes in an article Eli Lilly Profit Falls 39% on Patent Expirations The company said that patent expiration of the two treatments caused a 17% decline in volume during the quarter. [read post]
1 Sep 2015, 9:59 pm
District Court Finds Lilly Patent Infringed Based on Inducement of Infringement by Single Actor By Donald Zuhn -- Last week, in Eli Lilly and Company v. [read post]
24 Dec 2012, 6:30 am
”For more information, visit SEC Charges Eli Lilly and Company with FCPA ViolationsRelated articlesSEC Charges Lilly with Corruption Abroad: A Taste of Fines to Come SEC Charges Germany-Based Allianz SE with FCPA Violations SEC Charges TheStreet.com For False Financials SEC Charges Prominent Entrepreneur in Miami-Based Scheme [read post]
16 Mar 2018, 12:00 am
The SEC agreed with Eli Lilly’s reasoning, and concluded Eli Lilly could omit the proposal under Rule 14a-8(i)(10). [read post]
6 Apr 2009, 7:15 pm
Eli Lilly & Co., reversing the U.S. [read post]
24 Apr 2024, 5:59 am
The post Eli Lilly Received Approval for New Weight Loss Drug Zepbound appeared first on Illinois Injury and Mass Tort Lawyer Blog. [read post]
5 Oct 2020, 2:05 pm
Indianapolis, Indiana – Eli Lilly and Company (“Lilly”) filed suit on November 13, 2019 in the Southern District of Indiana against Defendant SensorRx seeking a declaratory judgment that it had not misappropriated trade secrets among other things. [read post]
10 Jun 2022, 1:22 pm
Amrit Mula was a top human resources officer at Eli Lilly and Co. for almost 15 years. [read post]
20 Aug 2008, 5:47 pm
Eli Lilly said Wednesday that it will pay $300 million for the rights to Posilac, Monsanto's controversial hormone to boost milk production in cows. [read post]
4 Aug 2011, 1:02 am
[via: Eli Lilly's law department goes into the classroom at InsideCounsel]Advertisement: * Find an In-House Counsel Job @ GoInhouse.com *Like this post? [read post]
25 Jan 2012, 1:06 pm
Indianapolis, IN - Patent attorneys for Eli Lilly and Company of Indianapolis, Indiana filed a patent infringement suit in the Southern District of Indiana alleging that Accord Healthcare, Inc., USA of Durham, North Carolina infringed patent no. 7,772,209, Antifolate combination therapies, which has been issued by the US Patent Office. [read post]
1 Aug 2006, 8:35 am
The FDA warned Eli Lilly and Co. for giving consumers misleading information about its cancer drug Alimta. [read post]
